Talaris Therapeutics Is A Biotechnology Company Founded In 2018Based In Louisvillekentuckywith Additional Operations In Boston And Houstonthe Company Initially Focused On Developing Cell Therapies For Solid Organ Transplantation And Severe Autoimmune Diseasesit Created A Proprietary Approach Called Facilitated Allo Hsct Therapywhich Aims To Induce Immune Tolerance Through Chimerism In June 2023Talaris Therapeutics Announced A Merger With Tourmaline Bioa Late Stage Clinical Biotechnology Companyfollowing This Mergerthe Combined Entity Will Operate Under The Name Tourmaline Bio And Will Focus On Advancing Tour006An Anti Il 6 Antibodyfor Treating Atherosclerotic Cardiovascular Disease And Thyroid Eye Diseasethis Marks A Significant Shift In The Company S Strategic Direction
